The role of antiapoptotic AKT and its related pathways have been extensively studied in cancer cells [46,47] and brain tissue [38,48]; however, so far, the role of the AKT/MDM2–p53 signaling pathway in IPC-mediated neuronal tolerance against ischemic injury remains elusive. This evidence concerns the gene AKT1 and cancer.